Last Price
0.004
Today's Change
0.00 (0.00%)
Day's Change
0.004 - 0.004
Trading Volume
900,246
Exchange: Australian Securities Exchange Australian Securities Exchange
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Timothy Charles Oldham BSc(Hons), LLB(Hons), Timothy Charles Oldham BSc(Hons), LLB(Hons),
Full Time Employees: 9 9
IPO Date: 2016-08-22 2016-08-22
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.
{uid}
{comment}
Just now